Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and <scp>BAL</scp> culture for diagnosis of <scp>COVID</scp> ‐19‐associated pulmonary aspergillosis-Reference-Cited by-同舟云学术

Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID ‐19‐associated pulmonary aspergillosis

Published:2022-08-25 Issue:10 Volume:65 Page:960-968
ISSN:0933-7407
Container-title:Mycoses
language:en
Short-container-title:Mycoses

Author:

Ghazanfari Mona¹²,Yazdani Charati Jamshid³,Davoodi Lotfollah⁴,Arastehfar Amir⁵,Moazeni Maryam¹²,Abastabar Mahdi¹²^ORCID,Haghani Iman¹²,Mayahi Sabah¹²,Hoenigl Martin⁶⁷⁸,Pan Weihua⁹^ORCID,Hedayati Mohammad T.¹²^ORCID

Affiliation:

1. Invasive Fungi Research Center, Communicable Diseases Institute Mazandaran University of Medical Sciences Sari Iran

2. Department of Medical Mycology, Faculty of Medicine Mazandaran University of Medical Sciences Sari Iran

3. Department of Biostatistics, Faculty of Health Mazandaran University of Medical Sciences Sari Iran

4. Antimicrobial Resistance Research Center/Department of Infectious Diseases, Faculty of Medicine Mazandaran University of Medical Sciences Sari Iran

5. Center for Discovery and Innovation, Hackensack Meridian Health Nutley New Jersey USA

6. Clinical and Translational Fungal‐Working Group University of California San Diego La Jolla California USA

7. Division of Infectious Diseases, Department of Internal Medicine Medical University of Graz Graz Austria

8. Division of Infectious Diseases and Global Public Health, Department of Medicine University of California, San Diego San Diego California USA

9. Medical Mycology, Shanghai Changzheng Hospital Second Military Medical University Shanghai China

Funder

Mazandaran University of Medical Sciences

Publisher

Wiley

Subject

Infectious Diseases,Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/myc.13518

Reference29 articles.

1. Improving outcome of fungal diseases - Guiding experts and patients towards excellence

2. Causes of Death in a Contemporary Cohort of Patients with Invasive Aspergillosis

3. Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients

4. Prevalence and outcome of invasive pulmonary aspergillosis in critically ill patients with liver cirrhosis: an observational study

5. Approach to invasive pulmonary aspergillosis in critically ill patients

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance of the IMMY® sona Aspergillus lateral flow assay for the detection of galactomannan in tracheal aspirate samples from Brazilian patients with COVID‐19‐associated pulmonary aspergillosis: Cross‐sectional and systematic review of literature;Mycoses;2024-08

2. Comparison of galactomannan lateral flow assay and enzyme immunoassay to identify Aspergillus spp. in bronchoalveolar lavage fluid;The Brazilian Journal of Infectious Diseases;2024-07

3. Diagnostic accuracy of galactomannan and lateral flow assay in invasive aspergillosis: A diagnostic meta-analysis;Heliyon;2024-07

4. Microbiological Diagnosis of Pulmonary Aspergillus Infections;Seminars in Respiratory and Critical Care Medicine;2024-01-16

5. Metagenomic next-generation sequencing for detecting Aspergillosis pneumonia in immunocompromised patients: a retrospective study;Frontiers in Cellular and Infection Microbiology;2023-12-22